There is an ancient reflex in us — when the skin cries out, the hand answers. Researchers at the University of Pittsburgh have now traced exactly why that answer makes things worse: scratching activates pain pathways that summon immune cells through a second, separate route, turning a fleeting irritation into a prolonged inflammatory siege. The body, it seems, is trying to protect itself and inadvertently prolonging its own suffering — a small but telling parable about the limits of instinct.
Why Scratching That Bug Bite Makes It Worse, According to Science
Cobertura Relacionada
Wales' only two-Michelin-star restaurant regained its five-star food hygiene rating after addressing violations includin…
BBC News · Aug 06 Loophole allows car washes and vape shops to sponsor foreign workers despite visa tighteningOver 1,900 small high-street businesses including car washes and vape shops retain licenses to sponsor skilled foreign w…
Newswise · Aug 06 Neuroimaging reveals how systemic diseases reshape brain structure and functionNeuroimaging studies demonstrate that systemic diseases profoundly affect brain structure and function, while brain diso…
Esquire Singapore · Aug 06 Five Watches Built to Last: Modern Designs Destined to Become ClassicsEsquire Singapore highlights five new watch models from luxury brands that prioritize timeless design over trends, featu…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
This article discusses dermatological research on itching mechanisms and has no geopolitical implications.
Lente Económico
Scientific research on itch-scratch cycles has minimal direct economic impact; primarily affects dermatology and over-the-counter anti-itch product markets with modest consumer awareness implications.
Consumers may increase purchases of anti-itch creams and menthol treatments based on scientific validation of dermatologist recommendations, potentially shifting spending from scratching-based relief to topical products. Impact is marginal as these products are already widely available.
Minimal regulatory implications. May support existing FDA guidance on OTC anti-itch treatments and dermatology best practices. Could inform public health messaging about skin care, though this is routine medical information.